Emerging trends in pharmaceutical design and drug manufacturing are shifting toward presenting the market with new ways to develop medications. Specialty medications continue to be a major area of pharmaceutical development and have become widely discussed in workers’ comp due to their significant costs. Although they represent approximately 1% of drug utilization, they account for nearly 7% of prescription drug costs and represent the fastest-growing segment of the U.S. pharmaceutical market. While specialty drug products are often associated with a hefty price tag, some can offer clinical advantages when deployed for the right patient at the right time, making careful oversight and patient selection imperative to achieving desired outcomes in this space. Watch the video blog to learn more.
More stories
Workers' Comp
Case Study
Big Picture, Big Success
Catastrophic Case Management Meet Lisa Armstrong, BSN, CRRN, RN-BC, CCM Lisa Armstrong has been a
Workers' Comp
Blog
Top Five Reasons You’ll Love DMEC 18
Can’t-miss events abound at this year’s premier disability conference
Workers' Comp
Article
StateWatch: Bill Review June/July 2018
Keep current with new legislation and its potential effect on your organization.
Workers' Comp
News Release
CCMC Elects Chikita Mann to Secretary Post
Genex Supervisor to Serve on the Commissioners' Executive CommitteeWAYNE, PA – July 25, 2018
Mitchell
Conference
Mitchell 2019 mPower Conference
Join u
Workers' Comp
News Release
Press Release - AAPAN Board of Directors to Appoint Kate Farley-Agee to AAPAN Executive Committee
Downers Grove, IL—July 19, 2018—Coventry is pleased to announce Kate Farley-Agee has been